IBA – Transparency Notification
20 Septembre 2023 - 6:00PM
IBA – Transparency Notification
IBA – TRANSPARENCY
NOTIFICATION
(Article 14, paragraph 1 of the law of 2
May 2007 on the disclosure of major holdings)
Louvain-la-Neuve, Belgium, September
20th, 2023 18:00
Summary of the notification
IBA (Ion Beam Applications), the world’s leading
provider of proton therapy solutions for the treatment of cancer,
announces that it has to issue a transparency notification, in
accordance with Article 14, al. 1 of the Transparency Law of May 2,
2007 on disclosure of major holdings, further to the notification
received on September 18th 2023.
In its notification, NS Partners Europe SA has
notified that the lowest threshold of 1% (statutory threshold) had
been crossed downwards.
Content of the notification
- Reason for the notification: Passive crossing of a
threshold
Downward
crossing of the lowest threshold
- Notification by: A parent undertaking or a controlling
person
- Persons subject to the notification
requirement:
- Date on which the threshold is crossed: 30/08/2023
- Threshold crossed (in %) : 1%
- Denominator : 40.595.290
- Notified details: (extract of the received notification
form)
- Full chain of controlled undertakings through which the
holding is effectively held
1. There is no natural person who directly or
indirectly hold a sufficient percentage of the voting rights or a
sufficient shareholding in the capitalof the company.2. There is no
natural person who control the company by other means (e.g. right
to appoint or revoke main directors, veto rights, etc.).As a
result, the ultimate controlling persons are the board members: Mr.
Paolo FARAONE, Mr. Christophe LENTSCHAT, and Mr. GrégoireNOTZ.
NS Partners Europe S.A. acts as AIFM of the fund
Lux-Investment Professionals SICAV-FIS S.A.NS Partners Europe S.A.,
in agreement with Lux-Investment Professionals Sicav-FIS S.A.
prospectus and the AIFM Voting right policy may exercise the voting
rights on a discretionary basis, without specific instructions from
the unit holder of the fund.
About IBAIBA (Ion Beam
Applications S.A.) is the world leader in particle accelerator
technology. The company is the leading supplier of equipment and
services in the field of proton therapy, considered to be the most
advanced form of radiation therapy available today. IBA is also a
leading player in the fields of industrial sterilization,
radiopharmaceuticals and dosimetry. The company, based in
Louvain-la-Neuve, Belgium, employs approximately 2.000 people
worldwide. IBA is a certified B Corporation (B Corp) meeting the
highest standards of verified social and environmental
performance.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).More
information can be found at: www.iba-worldwide.com
For further information, please
contact:
Valérie Van
ImpeParalegal
+32479267809legal@iba-group.com
- 20092023-IBA-Partners_transparency FR.docx
- 20092023-IBA-Partners_transparency EN
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024